| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,236 |
4,387 |
$432K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,007 |
853 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
728 |
634 |
$89K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
776 |
607 |
$84K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,390 |
1,949 |
$77K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,535 |
606 |
$72K |
| 96127 |
|
3,457 |
2,254 |
$66K |
| 92558 |
|
2,859 |
2,378 |
$56K |
| 99174 |
|
2,763 |
2,358 |
$44K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
418 |
347 |
$43K |
| 96160 |
|
2,713 |
1,668 |
$33K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
976 |
810 |
$31K |
| 99050 |
|
2,389 |
1,573 |
$25K |
| 99188 |
|
1,103 |
929 |
$20K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,658 |
957 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
426 |
368 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,440 |
1,146 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
731 |
615 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
46 |
44 |
$5K |
| 99384 |
|
33 |
24 |
$3K |
| 99383 |
|
17 |
15 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
104 |
86 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
46 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
61 |
52 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
13 |
$975.12 |
| 87807 |
|
47 |
39 |
$274.80 |
| 85018 |
|
1,655 |
1,308 |
$20.34 |
| 90696 |
|
44 |
40 |
$0.05 |
| 90686 |
|
704 |
581 |
$0.03 |
| 90620 |
|
91 |
67 |
$0.02 |
| 90633 |
|
326 |
266 |
$0.01 |
| 90671 |
|
356 |
334 |
$0.00 |
| 90648 |
|
13 |
13 |
$0.00 |
| 90710 |
|
98 |
81 |
$0.00 |
| 90715 |
|
43 |
38 |
$0.00 |
| 90670 |
|
116 |
109 |
$0.00 |
| 90734 |
|
78 |
60 |
$0.00 |
| 90651 |
|
182 |
154 |
$0.00 |
| 90697 |
|
235 |
225 |
$0.00 |
| 90680 |
|
200 |
183 |
$0.00 |
| 90619 |
|
49 |
42 |
$0.00 |
| 90723 |
|
12 |
12 |
$0.00 |